Healthcare Triangle is trading 7.31% down at $0.52 as the October 8, 2026, deadline to appeal Nasdaq’s delisting determination arrives. - Nasdaq found the company below the $1 minimum bid-price requirement; prior reverse splits make it ineligible for the usual compliance period. - Without an appeal, trading could be suspended October 12. - The company said it intended to request a hearing, but the available filing does not confirm it has done so.